Barclays Stays Overweight On Chimerix, Cuts Price Target By $53

By: via Benzinga
Shares of Chimerix Inc (NASDAQ: CMRX) dropped 81 percent this week, dropping almost to their 52-week low at ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.